RPG Life Sciences Schedules Board Meeting to Approve Q1 Financial Results
RPG Life Sciences Ltd has scheduled a Board of Directors meeting to review and approve its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company also confirmed the closure of its trading window for designated persons and their immediate relatives.The Board Meeting is set for Tuesday, July 28, 2026. During the meeting, the management plans to consider and approve the financial results and take on record the Limited Review Report pertaining thereto.
In addition to the board approval, the company has specified operational procedures regarding insider trading. The designated persons' trading window concerning the securities of RPG Life Sciences has been closed since July 1, 2026.
The trading restriction will remain in effect until a period of 48 hours following the public disclosure of the results on July 28, 2026. This measure is part of the company's internal procedures concerning fair disclosure and insider reporting standards.
RPGLIFE Stock Price Movement
Today, shares of RPG Life Sciences Limited gained 0.74% in the post-market session, settling at ₹2997.90 after trading concluded. The stock surged during the day, hitting an intraday high of ₹3082, which marked a new 52-week record for the company.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.